Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Liabilities: 2020-2024

Historic Total Liabilities for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $17.7 million.

  • Biofrontera's Total Liabilities rose 38.58% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 38.58%. This contributed to the annual value of $17.7 million for FY2024, which is 23.64% down from last year.
  • As of FY2024, Biofrontera's Total Liabilities stood at $17.7 million, which was down 23.64% from $23.1 million recorded in FY2023.
  • Biofrontera's 5-year Total Liabilities high stood at $41.9 million for FY2021, and its period low was $17.7 million during FY2024.
  • In the last 3 years, Biofrontera's Total Liabilities had a median value of $23.1 million in 2023 and averaged $22.6 million.
  • As far as peak fluctuations go, Biofrontera's Total Liabilities skyrocketed by 128.73% in 2021, and later plummeted by 35.52% in 2022.
  • Yearly analysis of 5 years shows Biofrontera's Total Liabilities stood at $18.3 million in 2020, then spiked by 128.73% to $41.9 million in 2021, then plummeted by 35.52% to $27.0 million in 2022, then declined by 14.32% to $23.1 million in 2023, then declined by 23.64% to $17.7 million in 2024.